2026 IMS Annual Meeting
- 00DAYS
- 00HRS
- 00MINS
- 00SECS
September 23 to September 25, 2026
Glasgow, Scotland
About the IMS
The International Myeloma Society (IMS) is a professional, scientific, and medical society established to bring together clinical and experimental scientists involved in the study of myeloma. The purpose of this society is to promote research, education, clinical studies (including diagnosis and treatment), workshops, conferences, and symposia on all aspects of multiple myeloma worldwide.
The IMS is a membership organization comprised of basic research scientists, and clinical investigators in the field along with physicians and other healthcare practitioners. IMS is governed by a Board of Directors representing practices from around the world and encourages and promotes the study of this expanding field through its annual International Myeloma Meeting.
About the Annual Meeting
The International Myeloma Society Meeting is the defining annual meeting in myeloma with a focus on both the basic, preclinical, and clinical aspects. This year’s program includes:
- Four thematic sessions:
- Newly Diagnosed Multiple Myeloma
- How to Treat First Relapse
- Blood-Based Technology for Diagnosis and Monitoring
- Monitoring Immune System and Preventing Infections and Adverse Effects
- Talks and symposia led by key opinion leaders in the myeloma community
- Keynote addresses
- Joint sessions with regulatory agencies and other organizations
- Meet the Expert sessions
- Oral Abstracts (Basic Biology, Preclinical Trials, Clinical Studies)
- Poster presentations and discussion sessions
- The 10th Nursing and Allied Health Symposium to be held on Wednesday, September 23, 2026
International Myeloma Society Annual Meeting
c/o SPARGO, Inc.
Phone: (703) 631-6200 / (888) 788-1552
Email: imsregistration@spargoinc.com
